Dec 04, · List of 22 Cancer Research Paper Topics. Are children with cancer more likely to develop it again as an adult? Cancer is a deadly disease but can it relate to the foods we eat, lifestyles we follow and the cultures we have adopt Oct 14, · Research related to the fund made news in late when a breast cancer vaccine developed by Cleveland Clinic immunologist Dr. Vincent Tuohy and his team received approval from the Food and Drug Possible environmental causes of breast cancer have also received more attention in recent years. While much of the science on this topic is still in its earliest stages, this is an area of active research. Reducing breast cancer risk
Auto shop fundraiser helps promising breast cancer research | Local News | blogger.com
Researchers around the world are working to find better ways to prevent, detect, and treat breast cancer, and to improve the quality of life of patients and survivors. Studies continue to uncover lifestyle factors and habits, as well as inherited genes, that affect breast cancer risk. Here are a few examples:. Researchers continue to look for medicines that might help lower breast cancer risk, especially women who are at high risk.
This type of research takes many years. It might be some time before meaningful results on any of these compounds are available. Circulating tumor cells CTCs are cancer cells that break away from the tumor and move into the bloodstream. Circulating tumor DNA ctDNA is DNA that is released into the bloodstream when cancer cells die. Researchers are investigating tests that measure the amount of CTCs and ctDNA in the blood of women with breast cancer, research paper about breast cancer.
Some studies have shown that in women with metastatic Stage 4 breast cancer, a high level of CTCs might predict a poorer outcome compared to women with a lower level.
Although more studies are needed before liquid biopsies could replace the traditional needle biopsy, some potential uses include:. Newer types of tests are being developed for breast imaging. Some of these are already being used in certain situations, while others are still being studied.
It will take time to see if they are as good as or better than those used today. Some of these tests include:. For more on these tests, see Newer and Experimental Breast Imaging Tests. It is known that chemotherapy can be helpful for many breast cancer patients. But predicting who will benefit the most or the least is still being studied. Sometimes there are significant side effects long- and short-term from chemotherapy, so having tests that can determine who really needs chemo would be useful.
Many studies are being done to evaluate different tests that can more accurately tell which patients would benefit from chemo and which patients could avoid it.
Since triple-negative breast cancers TNBC cannot be treated with hormone therapy or targeted therapy such as HER2 drugs, the treatment options are limited to chemotherapy. And although TNBC tends to respond well to initial chemotherapy, it tends to come back recur more frequently than other breast cancers. Inthe immunotherapy drug Atezolizumab Tecentriqwas approved along with the chemotherapy drug nab-paclitaxel Abraxane for use in women with advanced triple negative breast cancer that makes the PD-L1 protein.
Other potential targets for new breast cancer drugs have been identified in recent years. Drugs based on these targets, such as kinase inhibitors, research paper about breast cancer, are now being studied to treat triple-negative breast cancers, either by themselves, or in combination with chemotherapy. One example is the AKT inhibitor ipatasertib, which, when used with paclitaxel, shows promising results in treating women with TNBC as the first treatment. Another AKT inhibitor, capivasertib, is also showing encouraging results when given with paclitaxel, research paper about breast cancer.
Breast cancer cells are routinely tested for estrogen and progesterone receptors to help determine treatment options. Initial studies in women with breast cancer show some response when using the antiandrogen bicalutamide, to treat TNBC that has the androgen receptor. Bicalutamide is a drug that has been used to treat prostate cancer for many years. More studies in breast cancer are ongoing. There are trials looking at different medicines to try and research paper about breast cancer memory and brain symptoms after chemotherapy.
Other studies are evaluating if certain cardiac drugs, known as beta-blockers, can prevent the heart damage sometimes caused by common breast cancer drugs such as doxorubicin and trastuzumab.
Clinical trials are carefully controlled research studies that are done to get a closer look at promising new treatments or procedures.
Research paper about breast cancer trials are one way to get state-of-the art research paper about breast cancer treatment. In some cases, they may be the only way to get access to newer treatments. They are also the best way for doctors to learn better methods to treat cancer.
Still, they are not right for everyone. If you would like to learn more about clinical trials that might be right for you, start by asking your doctor if your clinic or hospital conducts clinical trials, or see Clinical Trials to learn more.
2020 EMBRACE Metastatic Breast Cancer Virtual Forum Series - Research Update for Triple-Negative MBC
, time: 1:00:59Breast Cancer Research | Articles
The Breast Cancer Research semipostal stamp, originally issued in , is being reissued in Mandated by Congress in and signed into law by President Bill Clinton, the Breast Cancer Research stamp was the first semipostal issued by the U.S. Postal Service® Nov 11, · By Hannah Caver, Staff Writer MOODY — The city of Moody presented a check to the Breast Cancer Research Foundation of Alabama on Tuesday, November 9 at 2 p.m. October is Breast Cancer Awareness Possible environmental causes of breast cancer have also received more attention in recent years. While much of the science on this topic is still in its earliest stages, this is an area of active research. Reducing breast cancer risk
No comments:
Post a Comment